Kaiser Health News
FEBRUARY 8, 2022
The penalties — a 1% reduction in Medicare payments over 12 months — are based on the experiences of Medicare patients discharged from the hospital between July 2018 and the end of 2019, before the pandemic began in earnest. The total amount of the penalties is determined by how much each hospital bills Medicare.
Healthcare Law Blog
JANUARY 10, 2022
On January 6, 2022 , the Centers for Medicare and Medicaid Services (“CMS”) issued the proposed rule on Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs (the “Proposed Rule”). Refining Definitions for Fully Integrated and Highly Integrated D-SNPs (§§ 422.2
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bill of Health
JULY 15, 2022
Government Patent Use to Promote Public Health in the United States: Overcoming Nonpatent Exclusivities. Am J Public Health. Cost Per Event Averted in Cancer Trials in the Adjuvant Setting From 2018 to 2022. Potential Medicare Part D Savings on Generic Drugs From the Mark Cuban Cost Plus Drug Company.
AIHC
JANUARY 28, 2022
For more information on filing compliance cost reports, attend the Medicare Cost Report Camp in March 2022 presented by KraftCPAs and sponsored by the American Institute of Healthcare Compliance. This is calculated based on the hospital’s relative share of uncompensated care nationally. This is known as the hospital “market basket.”
Healthcare Law Blog
NOVEMBER 1, 2022
CMS announced today a further extension until February 1, 2023, of the deadline for its publication of the long-awaited final rule on the use of extrapolation and the application of a fee-for-service adjuster (FFS Adjuster) in risk adjustment data validation (RADV) audits of Medicare Advantage organizations (MAOs). See 42 U.S.C.
Innovaare Compliance
MARCH 4, 2024
Until the enactment of the Medicare Modernization Act (MMA) in 2006 [1] , the Centers for Medicare & Medicaid Services does not cover most outpatient prescription drugs under Part B (“Part B drugs”). However, some drugs self-administered by Medicare beneficiaries at home are Part B eligible.
HIT Consultant
NOVEMBER 24, 2022
Health plans could, for example, consider covering OTC hearing devices as part of the hearing benefits package provided to their Medicare Advantage plan members. Instead of improving the hearing health of the consumer, the result may be additional hearing damage. Member satisfaction is key for health plans to stay competitive.
Expert insights. Personalized for you.
116 
Let's personalize your content